MEDPNC
MEDPNC
Claim
MEDPNC specializes in studying personalized treatments for cancer by analyzing the patient-specific protein network structures. It develops a method that proposes the optimal drug combination for each individual patient and also predicts the efficacy of the treatment. MEDPNC was founded in 2013 and is headquartered in Herzliya, Israel.MEDPNC specializes in studying personalized treatments for cancer by analyzing the patient-specific Show More
Alpha Score
Alpha Score
36.9
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0